NCT00393380 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- 2 years
- Other-event reporting threshold
- 5%
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Parathyroid Hormone (Teriparatide) | 8 / 13 | 8 / 13 | Not reported / Not reported |
Serious adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- notes
- Death
- organ System
- General disorders
- stats
- group Id
- EG000
- num Affected
- 8
- num At Risk
- 13
- num Events
- 8
- term
- Death
Other reported adverse events
- organ System
- General disorders
- stats
- group Id
- EG000
- num Affected
- 8
- num At Risk
- 13
- num Events
- 8
- term
- Death
Complete source fields
- event Groups
- description
- Parathyroid hormone after double umbilical cord blood transplant.
- id
- EG000
- other Num Affected
- 8
- other Num At Risk
- 13
- serious Num Affected
- 8
- serious Num At Risk
- 13
- title
- Parathyroid Hormone (Teriparatide)
- frequency Threshold
- 5
- other Events
- organ System
- General disorders
- stats
- group Id
- EG000
- num Affected
- 8
- num At Risk
- 13
- num Events
- 8
- term
- Death
- serious Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- notes
- Death
- organ System
- General disorders
- stats
- group Id
- EG000
- num Affected
- 8
- num At Risk
- 13
- num Events
- 8
- term
- Death
- time Frame
- 2 years
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle